Skip to main content

News

News
03/27/2024
Don't miss out on the latest updates from CMS, including the upcoming Health Equity Conference, value-based care strategy insights, and expanded coverage for personal care services in hospital settings.
Don't miss out on the latest updates from CMS, including the upcoming Health Equity Conference, value-based care strategy insights, and expanded coverage for personal care services in hospital settings.
Don't miss out on the latest...
03/27/2024
First Report Managed Care
News
03/26/2024
Discover the impact of manual processes and staffing challenges on payer enrollment and credentialing workflows in the 2024 State of Payer Enrollment and Credentialing Report by Medallion.
Discover the impact of manual processes and staffing challenges on payer enrollment and credentialing workflows in the 2024 State of Payer Enrollment and Credentialing Report by Medallion.
Discover the impact of manual...
03/26/2024
First Report Managed Care
News
03/26/2024

By Emry Lloyd

By Emry Lloyd
Clostridioides difficile is a bacterium that causes gastrointestinal issues in patients. This article describes how physicians can understand Clostridioides difficile and its makeup to determine how to treat or manage infection.
Clostridioides difficile is a bacterium that causes gastrointestinal issues in patients. This article describes how physicians can understand Clostridioides difficile and its makeup to determine how to treat or manage infection.
Clostridioides difficile is a...
03/26/2024
First Report Managed Care
News
03/18/2024
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
News
03/14/2024
Switching to two-step algorithm testing for Clostridioides difficile infection correlated with lower rates of treatment, helping to differentiate colonization from active infection, according to a study published in Clinical Microbiology and...
Switching to two-step algorithm testing for Clostridioides difficile infection correlated with lower rates of treatment, helping to differentiate colonization from active infection, according to a study published in Clinical Microbiology and...
Switching to two-step algorithm...
03/14/2024
First Report Managed Care
News
03/12/2024
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force...
03/12/2024
First Report Managed Care
News
03/05/2024
The Justice Department is investigating UnitedHealth’s ownership of the largest US health care insurer and its relationship with doctor groups and drug benefits amid concerns of potential antitrust violations.
The Justice Department is investigating UnitedHealth’s ownership of the largest US health care insurer and its relationship with doctor groups and drug benefits amid concerns of potential antitrust violations.
The Justice Department is...
03/05/2024
First Report Managed Care
News
03/04/2024

Emry Lloyd

Emry Lloyd
Every year, millions of necessary medical service claims are denied by health care providers; policymakers want to balance these denials for those who need care and how this affects patients with diabetic macular edema.
Every year, millions of necessary medical service claims are denied by health care providers; policymakers want to balance these denials for those who need care and how this affects patients with diabetic macular edema.
Every year, millions of...
03/04/2024
First Report Managed Care
News
02/27/2024
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part...
02/27/2024
First Report Managed Care
News
02/26/2024
The escalating concern over specialty drug costs for employers and health plan executives is driven by significant spending increases, reaching $315 billion in 2022, with specialty drugs comprising 50% of total spending despite their low...
The escalating concern over specialty drug costs for employers and health plan executives is driven by significant spending increases, reaching $315 billion in 2022, with specialty drugs comprising 50% of total spending despite their low...
The escalating concern over...
02/26/2024
First Report Managed Care